Cabungcag, Andres, Jr. G.
HRN: 23-35-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2023
CEFTRIAXONE 1G (VIAL)
08/03/2023
08/09/2023
IV
2gm
Q24H
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes